Novan President and CEO, Paula Brown Stafford Named Chairman of the Board
July 28, 2020 08:05 ET
|
Novan, Inc.
Expanded role of Ms. Stafford as Chairman reflects the Board’s confidence in her leadership of the Company and strategic direction Renowned pharmaceutical executive Robert Ingram retiring as Executive...
Novan to Host Live Audio Webcast of 2020 Annual Meeting of Stockholders
July 23, 2020 08:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2020 Annual...
Novan Anticipates Current Cash Position Provides Sufficient Capital to Conduct Additional SB206 Phase 3 Pivotal Trial
June 25, 2020 08:00 ET
|
Novan, Inc.
MORRISVILLE, N.C., June 25, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company anticipates that its current cash position will be...
Novan Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market
March 26, 2020 16:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., March 26, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company’s previously announced registered direct...
Novan Announces $8.0 Million Registered Direct Offering Priced At-the-Market
March 24, 2020 08:10 ET
|
Novan, Inc.
MORRISVILLE, N.C., March 24, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it has entered into definitive agreements with several institutional...
Novan Announces Closing of $5.95 Million Public Offering, including Partial Exercise of the Underwriter’s Option to Purchase Additional Securities
March 03, 2020 16:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., March 03, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company’s previously announced underwritten public...
Novan Announces Pricing of $5.5 Million Public Offering
February 27, 2020 23:20 ET
|
Novan, Inc.
MORRISVILLE, N.C., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced the pricing of the Company's previously announced underwritten public...
Novan Announces Proposed Public Offering
February 27, 2020 16:01 ET
|
Novan, Inc.
MORRISVILLE, N.C., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN) today announced that it intends to offer and sell a combination of shares of its common...
Novan Receives Phase 2 NIH Federal Grant of Approximately $1.0 Million
February 20, 2020 08:15 ET
|
Novan, Inc.
Provides funds to evaluate the mechanistic antiviral activity of WH602Novan to progress IND-enabling toxicology and pharmacology studies for WH602 Grant is additive to $223,000 Phase 1 NIH grant...
Novan Provides SB206 Program and Business Update
February 06, 2020 08:30 ET
|
Novan, Inc.
FDA grants Type C meeting for SB206 to be held on April 1, 2020Last subject completes last visit, Week 24 safety evaluationAdditional 12-week efficacy and safety data provided MORRISVILLE, N.C., Feb....